JAK2V617F-mutant megakaryocytes contribute to hematopoietic stem/progenitor cell expansion in a model of murine myeloproliferation

被引:0
|
作者
H Zhan
Y Ma
C H S Lin
K Kaushansky
机构
[1] Northport VA Medical Center,Division of Hematology
[2] Stony Brook University,Oncology, Department of Medicine
[3] Stony Brook University,Department of Medicine, Division of Hematology
[4] Office of the Sr Vice President,Oncology
[5] Health Sciences,Department of Pathology
[6] Stony Brook Medicine,undefined
来源
Leukemia | 2016年 / 30卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
The myeloproliferative neoplasms (MPNs) are characterized by hematopoietic stem/progenitor cell (HSPC) expansion and overproduction of mature blood cells. The JAK2V617F mutation is present in hematopoietic cells in a majority of patients with MPNs, but the mechanism(s) responsible for MPN stem cell expansion remain incomplete. One hallmark feature of the marrow in patients with MPNs is megakaryocyte (MK) hyperplasia. We report here that mice bearing a human JAK2V617F gene restricted exclusively to the MK lineage develop many of the features of a MPN. Specifically, these mice exhibit thrombocytosis, splenomegaly, increased numbers of marrow and splenic hematopoietic progenitors and a substantial expansion of HSPCs. In addition, wild-type mice transplanted with cells from JAK2V617F-bearing MK marrow develop a myeloproliferative syndrome with thrombocytosis and erythrocytosis as well as pan-hematopoietic progenitor and stem cell expansion. As marrow histology in this murine model of myeloproliferation reveals a preferentially perivascular localization of JAK2V617F-mutant MKs and an increased marrow sinusoid vascular density, it adds to accumulating data that MKs are an important component of the marrow HSPC niche, and that MK expansion might indirectly contribute to the critical role of the thrombopoietin/c-Mpl signaling pathway in HSPC maintenance and expansion.
引用
收藏
页码:2332 / 2341
页数:9
相关论文
共 50 条
  • [41] Mesenchymal stem cells from JAK2V617F mutant patients with primary myelolibrosis do not harbor JAK2 mutant allele
    Pieri, Lisa
    Guglielmelli, Paola
    Bogani, Costanza
    Bosi, Alberto
    Vannucchi, Alessandro M.
    LEUKEMIA RESEARCH, 2008, 32 (03) : 516 - 517
  • [42] Distinct roles for long-term hematopoietic stem cells and erythroid precursor cells in a murine model of Jak2V617F-mediated polycythemia vera
    Mullally, Ann
    Poveromo, Luke
    Schneider, Rebekka K.
    Al-Shahrour, Fatima
    Lane, Steven W.
    Ebert, Benjamin L.
    BLOOD, 2012, 120 (01) : 166 - 172
  • [43] COMPETITIVE POTENTIAL OF JAK2-V617F STEM CELLS
    Kubovcakova, L.
    Lundberg, P.
    Hao-Shen, H.
    Skoda, R.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 161 - 162
  • [44] Single Cell Analysis Of JAK2V617F Positive MPN Stem/Progenitor Cells In Chronic Phase and Leukemic Transformation
    Gerber, Jonathan M.
    Williams, Donna M.
    Rogers, Ophelia
    Morse, Sarah
    Zhang, Hao
    McDevitt, Michael A.
    Jones, Richard J.
    Spivak, Jerry L.
    Moliterno, Alison R.
    BLOOD, 2013, 122 (21)
  • [45] Hematopoietic clonal dominance, stem cell mutations, and evolutionary pattern of JAK2V617F allele burden in polycythemia vera
    Angona, Anna
    Alvarez-Larran, Alberto
    Bellosillo, Beatriz
    Martinez-Aviles, Luz
    Camacho, Laura
    Fernandez-Rodriguez, Concepcion
    Pairet, Silvia
    Longaron, Raquel
    Ancochea, Agueda
    Senin, Alicia
    Florensa, Lourdes
    Besses, Carles
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2015, 94 (03) : 251 - 257
  • [46] No influence of V617F mutation in JAK2 on outcome after allogeneic hematopoietic stem cell transplantation (HSCT) for myelofibrosis
    Ditschkowski, Markus
    Elmaagacli, Ahmet H.
    Trenschel, Rudolf
    Steckel, Nina K.
    Koldehoff, Michael
    Beelen, Dietrich W.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (12) : 1350 - 1351
  • [47] Characterization of murine JAK2V617F-positive myeloproliferative disease
    Bumm, Thomas G. P.
    Elsea, Collin
    Corbin, Amie S.
    Loriaux, Marc
    Sherbenou, Daniel
    Wood, Lisa
    Deininger, Jutta
    Silver, Richard T.
    Druker, Brian J.
    Deininger, Michael W. N.
    CANCER RESEARCH, 2006, 66 (23) : 11156 - 11165
  • [48] HOMOZYGOUS JAK2V617F DRIVES RAPID HEMATOPOIETIC STEM CELL PROLIFERATION AND DIFFERENTIATION AT THE EXPENSE OF SELF-RENEWAL
    Fink, Juergen
    Kent, David
    Li, Juan
    Hawkins, Edwin
    Lo Celso, Cristina
    Green, Anthony
    EXPERIMENTAL HEMATOLOGY, 2013, 41 (08) : S15 - S15
  • [49] DISTINCT EFFECTS OF RUXOLITINIB AND INTERFERON-ALPHA ON JAK2V617F MYELOPROLIFERATIVE NEOPLASM HEMATOPOIETIC STEM CELL POPULATIONS
    Bywater, Megan
    Austin, Rebecca
    Straube, Jasmin
    Mullally, Ann
    Milson, Michael
    Lane, Steven
    EXPERIMENTAL HEMATOLOGY, 2019, 76 : S60 - S60
  • [50] Evaluating Clonal Dominance in a Murine Knock-in Model of Jak2V617F MPN
    Mullally, Ann
    Poveromo, Luke
    Brumme, Kristina
    Al-Shahrour, Fatima
    Lane, Steven W.
    Shih, Alan H.
    Aifantis, Iannis
    Levine, Ross L.
    Ebert, Benjamin L.
    BLOOD, 2011, 118 (21) : 282 - 282